XTL BIOPHARMACEUTICALS LTD. Additional Paid in Capital
XTL BIOPHARMACEUTICALS LTD. (XTLB) had Additional Paid in Capital of $141.29 million as of 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:AdditionalPaidinCapital · last filed 2025-04-30
- 2024-12-31: Additional Paid in Capital $141.29M.
- 2023-12-31: Additional Paid in Capital $146.33M.
- 2022-12-31: Additional Paid in Capital $146.33M.
- 2022-06-30: Additional Paid in Capital $146.33M.
| Period end | Additional Paid in Capital |
|---|---|
| 2024-12-31 | $141.29M 20-F · filed 2025-04-30 |
| 2023-12-31 | $146.33M 20-F · filed 2025-04-30 |
| 2022-12-31 | $146.33M 20-F · filed 2023-03-22 |
| 2022-06-30 | $146.33M 6-K · filed 2022-08-24 |
| 2021-12-31 | $146.33M 20-F · filed 2023-03-22 |
| 2021-06-30 | $146.11M 6-K · filed 2021-08-24 |
| 2020-12-31 | $146.01M 20-F · filed 2022-03-30 |